Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
NEW YORK (Reuters Health) – In patients with atrial fibrillation undergoing radiofrequency catheter ablation, complication risks are higher with use of dabigatran for anticoagulation compared with uninterrupted warfarin,…
NEW YORK (Reuters Health) – Late lumen loss at 6 months is smaller with the Cre8 amphilimus-eluting stent than the Taxus paclitaxel-eluting stent in de novo percutaneous coronary…
NEW YORK (Reuters Health) – The benefits of preemptive percutaneous mitral commissurotomy (PMC) in asymptomatic patients with moderate mitral stenosis appear to outweigh the inherent risks of the…
NEW YORK (Reuters Health) – A proximal balloon occlusion device provided better protection against cerebral emboli than a filter device during coronary artery stenting (CAS) in the first…
NEW YORK (Reuters Health) – Three cardiologists from China say intracoronary administration of a glycoprotein IIb/IIIa receptor inhibitor (GPI) “can be recommended as a preferred regimen” during primary…
NEW YORK (Reuters Health) – Discontinuation of aspirin within 5 days of combined coronary artery bypass graft (CABG) and valve surgery is associated with an increased risk of…
NEW YORK (Reuters Health) – Percutaneous placement of a sirolimus-eluting stent (SES) is a safe and effective way to address either bare-metal (BMS) or drug-eluting (DES) in-stent restenosis,…
NEW YORK (Reuters Health) – The rate of radial artery occlusion after transradial catheterization increases with the size of arterial sheath used for the procedure, according to data…
NEW YORK (Reuters Health) – There is no solid evidence that drug-eluting stents (compared to bare-metal stents) increase the risk for stent thrombosis, death or myocardial infarction in…
NEW YORK (Reuters Health) – A direct comparison of four agents as monotherapy in drug-naive patients with type 2 diabetes shows that exenatide once-weekly, metformin, and pioglitazone provide…
